Brandes Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.9M | Buy |
|
|||||
|
2025
Q1 | $65.1M | Buy |
|
|||||
|
2024
Q4 | $46M | Buy |
|
|||||
|
2024
Q3 | $44.1M | Sell |
|
|||||
|
2024
Q2 | $44.2M | Buy |
|
|||||
|
2024
Q1 | $46.5M | Buy |
|
|||||
|
2023
Q4 | $39.5M | Buy |
|
|||||
|
2023
Q3 | $24.8M | Buy |
|
|||||
|
2023
Q2 | $23.2M | Buy |
|
|||||
|
2023
Q1 | $22.8M | Buy |
|
|||||
|
2022
Q4 | $752K | Sell |
|
|||||
|
2022
Q3 | $17.5M | Buy |
|
|||||
|
2022
Q2 | $30.9M | Sell |
|
|||||
|
2022
Q1 | $34.9M | Sell |
|
|||||
|
2021
Q4 | $38.1M | Sell |
|
|||||
|
2021
Q3 | $33.3M | Sell |
|
|||||
|
2021
Q2 | $35.7M | Buy |
|
|||||
|
2021
Q1 | $31.5M | Buy |
|
|||||
|
2020
Q4 | $28.1M | Buy |
|
|||||
|
2020
Q3 | $27.4M | Sell |
|
|||||
|
2020
Q2 | $38.3M | Sell |
|
|||||
|
2020
Q1 | $47.3M | Sell |
|
|||||
|
2019
Q4 | $70.9M | Sell |
|
|||||
|
2019
Q3 | $68.8M | Sell |
|
|||||
|
2019
Q2 | $74.2M | Sell |
|
|||||
|
2019
Q1 | $87.1M | Buy |
|
|||||
|
2018
Q4 | $78.1M | Sell |
|
|||||
|
2018
Q3 | $90.3M | Sell |
|
|||||
|
2018
Q2 | $94.5M | Sell |
|
|||||
|
2018
Q1 | $93.4M | Buy |
|
|||||
|
2017
Q4 | $80.3M | Buy |
|
|||||
|
2017
Q3 | $86.6M | Sell |
|
|||||
|
2017
Q2 | $145M | Sell |
|
|||||
|
2017
Q1 | $142M | Buy |
|
|||||
|
2016
Q4 | $121M | Sell |
|
|||||
|
2016
Q3 | $152M | Sell |
|
|||||
|
2016
Q2 | $183M | Sell |
|
|||||
|
2016
Q1 | $181M | Buy |
|
|||||
|
2015
Q4 | $174M | Sell |
|
|||||
|
2015
Q3 | $180M | Buy |
|
|||||
|
2015
Q2 | $180M | Buy |
|
|||||
|
2015
Q1 | $179M | Buy |
|
|||||
|
2014
Q4 | $140M | Sell |
|
|||||
|
2014
Q3 | $157M | Buy |
|
|||||
|
2014
Q2 | $134M | Buy |
|
|||||
|
2014
Q1 | $116M | Buy |
|
|||||
|
2013
Q4 | $115M | Buy |
|
|||||
|
2013
Q3 | $95.2M | Sell |
|
|||||
|
2013
Q2 | $96.5M | Buy |
|